PMC
LIVE

Serial Number

79303122

Owner

PharmaMedic Consultancy Limited

Attorney

William C. Wright

Filing Date

Aug 26, 2020

Add to watchlist:

No watchlists yet
View on USPTO

PMC Trademark

Serial Number: 79303122 • Registration: 6504732

PMC is a trademark filed by PharmaMedic Consultancy Limited on August 26, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

PharmaMedic Consultancy Limited

The London Bioscience Innovation Centre

Entity Type: 24

Trademark Details

Filing Date

August 26, 2020

Registration Date

October 5, 2021

Published for Opposition

July 20, 2021

Goods & Services

Business project management; Business intelligence services; Business analysis; Business data analysis; Business strategy development and planning; Design and development of marketing, publicity and advertising materials; Development and planning of marketing, publicity and advertising strategies; Business introduction, namely, business networking services; Business representation, namely, public relations agency services; Consultancy, advisory and information services relating to all of the foregoing; Business, marketing, publicity, advertising, business risk management and business development and formation consultancy, advisory and information services

Legal services; Legal services in relation to representation before regulatory authorities; Consultancy, advisory and information services relating to all of the foregoing; Consultancy, advisory and information services relating to legal and regulatory affairs in the fields of medicine and pharmacy and in the field of medical devices, machines, instruments, equipment and apparatus

Pharmacovigilance services, namely, the identification, detection, assessment, analysis, monitoring and prevention of adverse effects in relation to pharmaceuticals; Consultancy, advisory and information services relating to all of the foregoing; Medical and pharmaceutical consultancy, advisory and information services; Consultancy, advisory and information services relating to medicines and pharmaceuticals and to the operation and efficacy of medical devices, machines, instruments, equipment and apparatus

Industrial analysis and industrial research in the fields of medicine, biotechnology and pharmacy and in the field of medical devices, machines, instruments, equipment and apparatus; Industrial design services; Quality control and quality authentication services in the fields of medicine, biotechnology and pharmacy and in the field of medical devices, machines, instruments, equipment and apparatus; Medical and pharmaceutical research; Design and development of medical, pharmaceutical and clinical studies; Design and development of medical experiments, treatments and procedures; Design and development of clinical protocols; Analysis and evaluation of medicines and pharmaceuticals; Analysis and evaluation of medical devices, machines, instruments, equipment and apparatus; Consultancy, advisory and information services relating to all of the foregoing; Design and development of packaging; Medical writing, namely, preparation of regulatory documentation relating to medicines and pharmaceuticals

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 18, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 25, 2022 FICS
FINAL DISPOSITION PROCESSED
Mar 25, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 5, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Oct 5, 2021 R.PR
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
Jul 21, 2021 CREV
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 20, 2021 NPUB
PUBLISHED FOR OPPOSITION
Jul 20, 2021 PUBO
USPTO CORRECTION PROCESSED BY IB
Jul 10, 2021 RINX
CORRECTION TRANSACTION RECEIVED FROM IB
Jul 10, 2021 CRCV
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 30, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 17, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Jun 17, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jun 17, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Jun 17, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jun 17, 2021 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jun 15, 2021 GNFN
FINAL REFUSAL E-MAILED
Jun 15, 2021 GNFR
FINAL REFUSAL WRITTEN
Jun 15, 2021 CNFR
CORRECTION SENT TO IB
Jun 9, 2021 CRSN
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 9, 2021 TEME
CORRECTION CREATED FOR IB
Jun 9, 2021 CRCR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 8, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2021 TROA
REFUSAL PROCESSED BY IB
Apr 5, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 12, 2021 RFCS
REFUSAL PROCESSED BY MPU
Mar 12, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 6, 2021 RFCR
NON-FINAL ACTION WRITTEN
Mar 5, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Feb 9, 2021 MAFR
ASSIGNED TO EXAMINER
Feb 3, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 3, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 2, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 28, 2021 REPR